SNHG1 and colorectal carcinoma: Results demonstrate that SNHG1 silencing inhibits proliferation and migration of CRC cells, and that miR‐137 inhibitor abrogates this inhibition, indicating that SNHG1 oncogenic activities, both in vivo and in vitro, are mediated through regulation of miR‐137 expression.